| Oct-2023 | A RANDOMISED, DOUBLE - BLIND, PHASE 3, NON-INFERIORITY TRIAL OF PRADEFOVIR MESYLATE VERSUS TENOFOVIR DISOPROXIL FUMARATE FOR PAITENTS WITH CHRONIC HEPATITIS B VIRUS INFECTION | Gao, Yanhang; Wang, Zhongfeng; Wang, Xinrui; Kong, Fei; Wu, Guicheng; Zhang, Guoqiang; Li, Guang-Ming; Yao, Lvfeng; Liu, Weidong; Shang, Jia; Yu, Yunsong; Zhao, Weifeng; Hou, Jinlin; Dang, Shuangsuo; Yuan, Shufen; Hu, Guoxin; Zhong, Bei; Chen, Hui; Chen, Suling; Dong, Xiaoping; Xie, Xiangping; Liu, Zhenguo; Zhang, Zong; Song, Xinwen; Mao, Qing; Jiang, Yongfang; Meng, Chenxin; Yuan, Zhaoxu; Su, Zhijun; Mao, Qianguo; Bai, Yichun; Yu, Lei; Tan, Youwen; Fan, Huizhen; Jiao, Zhiyong; Fu, Xihua; Sun, Qingfeng; Xu, Yuanyuan; Yan, Xuebing; Liu, Jinfeng; Gao, Yufeng; Gao, Hainv; Chen, Guangxia; Huang, Jianwei; Cui, Hesong; Wu, Shihong; Lu, Xiaobo; Liu, Zhihong; Liu, Fengjun; Li, Xiangjun; Sun, Shuilin; Ding, Guofeng; Han, Tao; Wang, Xiaozhong; Zhao, Wenhai; Xiang, Mingque; Chen, Xuebing; He, Wenyan; Lu, Shuang; Zeng, Wenting; Hu, Qinming; Zhang, Dengke; Jin, Weili; Wang, Daidi; Wen, Xiuhong; Wang, Yuan; Liu, Nini; Niu, Junqi |
